
    
      One approach to improve the immunogenicity of an HIV-1 subunit protein vaccine is to combine
      the immunogen with an adjuvant.

      Healthy volunteers receive intramuscular injections of rgp120/HIV-1SF2 with MF59 adjuvant
      emulsion or MF59 alone at months 0, 1, 6, 9, 10 and 12 (was months 0, 1, 6 and 10, amended
      12/19/96).
    
  